Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of tranexamic acid (TXA), lidocaine, and epinephrine is used in various surgical procedures to manage bleeding and provide local anesthesia. ## Efficacy and Usage This drug combination has been studied in several surgical contexts, particularly in plastic surgery procedures like blepharoplasty (eyelid surgery) and facelifts. The components serve different purposes: - **Tranexamic acid (TXA)**: An anti-fibrinolytic agent that helps reduce bleeding - **Lidocaine**: A local anesthetic that provides pain relief - **Epinephrine**: A vasoconstrictor that reduces bleeding by constricting blood vessels Interestingly, a prospective randomized control trial found that TXA combined with lidocaine and epinephrine actually **increased** intraoperative bleeding compared to lidocaine with epinephrine alone during upper blepharoplasty. This contradicts the expected outcome, as TXA is typically used to reduce bleeding. In contrast, for facelift surgery, local infiltration of TXA combined with lidocaine and epinephrine solution was found to decrease rebound bleeding and reduce the time required to gain hemostasis. The total surgical time saving was approximately 25 to 60 minutes. ## Administration Methods The combination is typically administered through: 1. Subcutaneous injection around the surgical site 2. Local infiltration before surgical procedures 3. Application of gauze impregnated with the solution on surgical wounds ## Safety Considerations The researchers who found increased bleeding with this combination in blepharoplasty concluded that "TXA combined with lidocaine and epinephrine injected subcutaneously should be avoided until additional relevant data are obtained". They recommended further drug interaction studies between TXA and epinephrine. For patients considering this combination, it's important to note that the efficacy may vary depending on the specific surgical procedure and individual factors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on tranexamic acid + lidocaine + epinephrine.